HER2 Support Group Forums
>
Breast Cancer Meeting Highlights
ARX788: A potential new treatment after T-DM1, Enhertu.
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Today's Posts
Search
Breast Cancer Meeting Highlights
News fro recent ASCO and San Antonio Meetings
Search Forums
Show Threads
Show Posts
Advanced Search
Search Gallery
Advanced Search
Go to Page...
Thread Tools
Display Modes
01-05-2021, 03:24 PM
#
1
Nguyen
Senior Member
Join Date: Nov 2005
Posts: 531
ARX788: A potential new treatment after T-DM1, Enhertu.
For some reason I can not post in "Articles of interest" section.
https://www.targetedonc.com/view/fda...BnbWFpbC5jb20=
http://ambrx.com/ambrx-presents-phas...cer-symposium/
ARX788, a Site-specific anti-HER2 Antibody Drug Conjugate, Demonstrates Potent and Selective Activity in HER2 Low and T-DM1 Resistant Breast and Gastric Cancers
https://sci-hub.se/https://mct.aacrj....full-text.pdf
Nguyen
View Public Profile
Send a private message to Nguyen
Find More Posts by Nguyen
«
Previous Thread
|
Next Thread
»
Thread Tools
Show Printable Version
Display Modes
Linear Mode
Switch to Hybrid Mode
Switch to Threaded Mode
Posting Rules
You
may not
post new threads
You
may not
post replies
You
may not
post attachments
You
may not
edit your posts
BB code
is
On
Smilies
are
On
[IMG]
code is
On
HTML code is
On
Forum Rules
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
12:59 PM
.